ATE427320T1 - Behandlung von infektionen verursacht von mikroorganismen - Google Patents

Behandlung von infektionen verursacht von mikroorganismen

Info

Publication number
ATE427320T1
ATE427320T1 AT02777534T AT02777534T ATE427320T1 AT E427320 T1 ATE427320 T1 AT E427320T1 AT 02777534 T AT02777534 T AT 02777534T AT 02777534 T AT02777534 T AT 02777534T AT E427320 T1 ATE427320 T1 AT E427320T1
Authority
AT
Austria
Prior art keywords
microorganisms
treatment
infections caused
antibody
daptomycin
Prior art date
Application number
AT02777534T
Other languages
English (en)
Inventor
James Peter Burnie
Ruth Christine Matthews
Original Assignee
Neutec Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Ltd filed Critical Neutec Pharma Ltd
Application granted granted Critical
Publication of ATE427320T1 publication Critical patent/ATE427320T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02777534T 2001-11-22 2002-11-13 Behandlung von infektionen verursacht von mikroorganismen ATE427320T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0127983.5A GB0127983D0 (en) 2001-11-22 2001-11-22 Treatment of micro-organism infection

Publications (1)

Publication Number Publication Date
ATE427320T1 true ATE427320T1 (de) 2009-04-15

Family

ID=9926237

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02777534T ATE427320T1 (de) 2001-11-22 2002-11-13 Behandlung von infektionen verursacht von mikroorganismen

Country Status (18)

Country Link
US (3) US20050118162A1 (de)
EP (2) EP1964851A1 (de)
JP (1) JP2005511645A (de)
CN (2) CN100371348C (de)
AT (1) ATE427320T1 (de)
AU (2) AU2002339159B2 (de)
BR (1) BR0214363A (de)
CA (1) CA2465072A1 (de)
DE (1) DE60231825D1 (de)
DK (1) DK1446425T3 (de)
ES (1) ES2322756T3 (de)
GB (1) GB0127983D0 (de)
NO (2) NO20042604L (de)
NZ (1) NZ533623A (de)
PL (1) PL369536A1 (de)
PT (1) PT1446425E (de)
RU (1) RU2303460C2 (de)
WO (1) WO2003046007A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127983D0 (en) * 2001-11-22 2002-01-16 Neutec Pharma Plc Treatment of micro-organism infection
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
JP5248032B2 (ja) * 2007-04-23 2013-07-31 株式会社Ａｄｅｋａ ケイ素含有化合物、硬化性組成物及び硬化物
JP5248033B2 (ja) * 2007-04-23 2013-07-31 株式会社Ａｄｅｋａ ケイ素含有化合物、硬化性組成物及び硬化物
US20100113355A1 (en) 2007-04-27 2010-05-06 Naresh Chennamsetty Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
WO2008132174A1 (en) * 2007-04-27 2008-11-06 Novartis Ag An immunoglobulin composition
MX2011012248A (es) 2009-05-18 2012-02-29 Univ Wuerzburg J Maximilians Anticuerpos o sus fragmentos dirigidos contra un epitope de staphylococcus aureus de isaa o isab.
TR201809128T4 (tr) * 2009-07-15 2018-07-23 Aimm Therapeutics Bv Gram-pozitif bakterilere spesifik bağlanan bileşikler.
US9005579B2 (en) * 2010-01-05 2015-04-14 Contrafect Corporation Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
EP2627292B1 (de) 2010-10-15 2018-10-10 Clearside Biomedical, Inc. Vorrichtung für okularen zugang
CA2815342A1 (en) * 2010-10-20 2012-04-26 Medimmune, Llc Methods for processing inclusion bodies
AU2014259694B2 (en) 2013-05-03 2018-11-08 Clearside Biomedical, Inc. Apparatus and methods for ocular injection
RU2572341C2 (ru) * 2013-09-20 2016-01-10 Федеральное государственное бюджетное учреждение Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе Российской академии медицинских наук (ФГБУ "НИИНА" РАМН) АНТИБИОТИК ИНА 5812, ШТАММ-ПРОДУЦЕНТ Streptomyces roseoflavus ИНА-Ас-5812 И СПОСОБ ПОЛУЧЕНИЯ АНТИБИОТИКА
WO2017192565A1 (en) 2016-05-02 2017-11-09 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
US10973681B2 (en) 2016-08-12 2021-04-13 Clearside Biomedical, Inc. Devices and methods for adjusting the insertion depth of a needle for medicament delivery
US12090294B2 (en) 2017-05-02 2024-09-17 Georgia Tech Research Corporation Targeted drug delivery methods using a microneedle

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
NZ291659A (en) * 1994-09-06 2001-04-27 Galagen Inc Use in the manufacture of a medicament of an antibody having specific activity against Clostridium difficile, and pharmaceutical compositions comprising Anti-Clostridium difficile bovine immunoglobulin concentrate; for treating diseases associated with Clostridium difficile
GB9614274D0 (en) * 1996-07-06 1996-09-04 Univ Manchester Treatment and diagnosis of infections of gram positive cocci
GB9806762D0 (en) 1998-03-31 1998-05-27 Neutec Pharma Plc Treatment and diagnosis of staphylococcal infections
GB0127983D0 (en) * 2001-11-22 2002-01-16 Neutec Pharma Plc Treatment of micro-organism infection

Also Published As

Publication number Publication date
US20050118162A1 (en) 2005-06-02
DE60231825D1 (de) 2009-05-14
RU2303460C2 (ru) 2007-07-27
CN100371348C (zh) 2008-02-27
US20070202116A1 (en) 2007-08-30
GB0127983D0 (en) 2002-01-16
BR0214363A (pt) 2004-10-26
AU2002339159B2 (en) 2008-06-05
EP1446425A2 (de) 2004-08-18
CA2465072A1 (en) 2003-06-05
EP1964851A1 (de) 2008-09-03
CN1589280A (zh) 2005-03-02
JP2005511645A (ja) 2005-04-28
DK1446425T3 (da) 2009-07-20
RU2004118716A (ru) 2005-03-27
NO20042604L (no) 2004-06-21
US20080171054A1 (en) 2008-07-17
CN101254304A (zh) 2008-09-03
WO2003046007A3 (en) 2004-03-11
AU2008212001A1 (en) 2008-09-25
PL369536A1 (en) 2005-05-02
PT1446425E (pt) 2009-07-01
NO20081575L (no) 2004-06-21
NZ533623A (en) 2005-12-23
EP1446425B1 (de) 2009-04-01
AU2002339159A1 (en) 2003-06-10
WO2003046007A2 (en) 2003-06-05
ES2322756T3 (es) 2009-06-26

Similar Documents

Publication Publication Date Title
NO20081575L (no) Behandling av mikroorganismeinfeksjoner
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
CY1109984T1 (el) Παραλλαγες gla πεδιου παραγοντα vii ή viia
ATE258057T1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
SE9101838D0 (sv) Novel peptides and their use
IL132933A0 (en) Composition for the treatment of diarrheal disease
DE60228136D1 (de) Cytokin-proteinfamilie
DE60332425D1 (de) 5t4-antigen-peptidepitope der mhc klasse ii
ATE201693T1 (de) Hämoregulierende peptide
GB0203419D0 (en) Peptide
ATE441713T1 (de) Tumorantigenprotein und dessen verwendung
SE9700244D0 (sv) Novel antibacterial protein
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
WO2002085934A3 (fr) Peptides antibacteriens, les compositions les contenant et leurs utilisations
NZ508812A (en) Peptides for the prevention or treatment of HIV
WO2004042043A3 (en) Crystal structures of bacterial ribulose-phosphate 3-epimerases
WO2001058471A3 (en) Novel amino acid and peptide inhibitors of staphylococcus virulence
ATE212839T1 (de) Hämoregulatorische verbindungen
WO2004041856A3 (en) Crystal structures of bacterial inorganic pyrophosphatases
WO2003027274A3 (en) Purified polypeptides from pseudomonas aeruginosa
WO2003048187A3 (en) Peptides and use thereof in therapeutic agents against hiv infection
WO2004058811A3 (en) Crystal structures of yhhf polypeptides
DE602004003508D1 (de) Aus pflanzen gewonnene peptide mit wasserreinigender und antimikrobieller wirkung
HK1045701A1 (zh) Fima菌毛基疫苗
CO4820441A1 (es) Antigeno bm 95 de la garrapata boophilus microplus, aislamiento, secuencia, adn recombinantes, microorganismos transformados y preparacion vacunal

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1446425

Country of ref document: EP

REN Ceased due to non-payment of the annual fee